Cited by 77Alzheimer's disease research and treatmentsCellular transport and secretionNeuroinflammation and Neurodegeneration Mechanisms

Sorting Nexin 27 Regulates Aβ Production through Modulating γ-Secretase Activity

Open access
Wang, Xin, Huang, Timothy, Zhao, Yingjun, Zheng, Qiuyang, Thompson, Robert C., Bu, Guojun, Zhang, Yun-wu, Hong, Wanjin +1 more·2014·Cell Reports

Abstract

Patients with Down syndrome (DS) invariably develop Alzheimer's disease (AD) pathology in their 40s. We have recently found that overexpression of a chromosome 21-encoded microRNA-155 results in decreased levels of the membrane trafficking component, SNX27, diminishing glutamate receptor recycling and thereby impairing synaptic functions in DS. Here, we report a function of SNX27 in regulating β-amyloid (Aβ) generation by modulating γ-secretase activity. Downregulation of SNX27 using RNAi increased Aβ production, whereas overexpression of full-length SNX27, but not SNX27ΔPDZ, reversed the RNAi-mediated Aβ elevation. Moreover, genetic deletion of Snx27 promoted Aβ production and neuronal loss, whereas overexpression of SNX27 using an adeno-associated viral (AAV) vector reduced hippocampal Aβ levels in a transgenic AD mouse model. SNX27 associates with the γ-secretase complex subunit presenilin 1; this interaction dissociates the γ-secretase complex, thus decreasing its proteolytic activity. Our study establishes a molecular mechanism for Aβ-dependent pathogenesis in both DS and AD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2014.09.037

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • SNX27 limits Aβ production through interaction with PS1 destabilizing the γ-secretase complex, and enhances non-amyloidogenic APP processing by promoting APP recycling via SORLA.

    “SNX27 regulates APP processing via two pathways: SNX27 can limit Aβ production through the interaction with PS1 which leads to destabilization of γ-secretase complex; in addition, SNX27 can enhance non-amyloidogenic APP processing through promoting the recycling of APP to the cell surface via interacting with SORLA [47, 48].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 56 · Cited by 77

Authors
Wang, X., Huang, T., Zhao, Y., Zheng, Q., Thompson, R. C., Bu, G., Zhang, Y.-W., Hong, W., & Xu, H.
Affiliations
  • Sanford Burnham Prebys Medical Discovery Institute (US)
  • Xiamen University (CN)
Corresponding author
Xu, Huaxi
Venue
Cell Reports
Publisher
Elsevier BV
Published
2014-11
Volume
9
Issue
3
Pages
1023-1033
ISSN
2211-1247 (ISSN-L)
OpenAlex
W1991466748
Cited by
77
References
56
Citations by year
2026: 3 · 2025: 4 · 2024: 12 · 2023: 4 · 2022: 6 · 2021: 4 · 2020: 7 · 2019: 5 · 2018: 7 · 2017: 8 · 2016: 10 · 2015: 6 · 2014: 1
FWCI
5.56
Type
journal article
Language
en
Open access
Locations
  • Cell Reports (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Rare & Special e-Zone (The Hong Kong University of Science and Technology) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • National Institute on Aging (P01AG030128, R01AG044420, R01AG038710, R01AG027924, R01AG030197, R01AG021173, RF1AG046205, R21AG049247)
  • National Institute of Neurological Disorders and Stroke (R01NS046673, P01NS074969)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
SNX27, amyloid-beta production, gamma-secretase, presenilin 1, Down syndrome, Alzheimer's disease, chromosome 21, miR-155, PDZ domain, neuronal loss, hippocampus, adeno-associated virus vectors
MeSH terms
Alzheimer Disease, Animals, Disease Models, Animal, HeLa Cells, Humans, Mice, Transgenic, Models, Biological, Neurons, Protein Binding, Amyloid beta-Peptides, Gene Deletion, Protein Subunits, Receptors, Notch, Presenilin-1, Amyloid Precursor Protein Secretases, HEK293 Cells, Sorting Nexins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review